FDA Clearance Tracker · K163591
BD PosiFlush Heparin Lock Flush Syringe
Last checked: Nov 19, 2026Latest source record: Feb 27, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Feb 27, 2017
Substantially Equivalent
Time to decision
69 days
Received Dec 20, 2016. Calendar days, including time FDA spent waiting on the applicant.
Pathway
510(k)
Special
Device class
Class II
The decision
- FDA number
- K163591
- Device name
- BD PosiFlush Heparin Lock Flush Syringe
- Applicant
- Becton, Dickinson and Company
- Applicant location
- Franklin Lakes, NJ
- Received
- Dec 20, 2016
- Decided
- Feb 27, 2017
- Decision
- Substantially Equivalent
- Submission type
- Special
Device type
- Device type
- Heparin, Vascular Access Flush (NZW)
- Device class
- Class II
- Regulation
- 21 CFR 880.5200
- Specialty
- Hospital Medicine & Nursing
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- It is not the first decision under product code NZW. The earliest in FDA's data is K023740, decided May 13, 2003.
- It is not on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026). FDA does not publish which devices hold the designation before they are authorized, and the list is updated only a few times a year.
Source documents
- FDA database record for K163591
- 510(k) summary (PDF) · FDA posts these some weeks after the decision, so a recent one may not open yet.
The predicate devices this clearance relied on are named in the summary document. We do not extract them yet.
Other decisions for Becton, Dickinson and Company
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K252344 · Decided Oct 16, 2026 · 445 days after receipt
Device type: Tubes, Vials, Systems, Serum Separators, Blood Collection (JKA) · Laboratory Medicine & Pathology
K262163 · Decided Sep 14, 2026 · 80 days after receipt
Device type: Culture Media, Antimicrobial Susceptibility Test, Mueller Hinton Agar/Broth (JTZ) · Laboratory Medicine & Pathology
K260128 · Decided Apr 15, 2026 · 89 days after receipt
Device type: Tubes, Vials, Systems, Serum Separators, Blood Collection (JKA) · Laboratory Medicine & Pathology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.